Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Achieved revenues in Q4 2023 of $291 million and full year 2023 of $1.0 billion Accelerating progress toward expanding pipeline via Phase 3 COVID-19-Influenza...
New Zealand Johnc Jacobs Ali Chartan Erika Schultz Leverage Technology Platform Serum Institute Of India Pvt
Source: prnewswire.com